EC Healthcare Yönetim

Yönetim kriter kontrolleri 3/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Leslie Lu

İcra Kurulu Başkanı

HK$4.8m

Toplam tazminat

CEO maaş yüzdesi	99.6%
CEO görev süresi	less than a year
CEO sahipliği	n/a
Yönetim ortalama görev süresi	2.3yrs
Yönetim Kurulu ortalama görev süresi	8.8yrs

Son yönetim güncellemeleri

Recent updates

EC Healthcare (HKG:2138) Will Want To Turn Around Its Return Trends

Nov 13

Little Excitement Around EC Healthcare's (HKG:2138) Revenues As Shares Take 31% Pounding

Sep 05

EC Healthcare (HKG:2138) Might Be Having Difficulty Using Its Capital Effectively

Jul 26

Slammed 26% EC Healthcare (HKG:2138) Screens Well Here But There Might Be A Catch

Dec 24

EC Healthcare's (HKG:2138) Dividend Is Being Reduced To HK$0.005

Dec 08

Here's What's Concerning About EC Healthcare's (HKG:2138) Returns On Capital

Dec 01

At HK$3.13, Is EC Healthcare (HKG:2138) Worth Looking At Closely?

Sep 15

EC Healthcare (HKG:2138) Is Paying Out A Dividend Of HK$0.042

Aug 24

Is EC Healthcare (HKG:2138) Using Too Much Debt?

Aug 10

EC Healthcare (HKG:2138) Has Announced A Dividend Of HK$0.042

Jul 14

EC Healthcare (HKG:2138) Will Pay A Dividend Of HK$0.042

Jun 26

Is There Now An Opportunity In EC Healthcare (HKG:2138)?

Jun 15

Be Wary Of EC Healthcare (HKG:2138) And Its Returns On Capital

May 12

Is EC Healthcare (HKG:2138) Potentially Undervalued?

Mar 08

EC Healthcare (HKG:2138) Will Want To Turn Around Its Return Trends

Feb 03

EC Healthcare (HKG:2138) Is Paying Out Less In Dividends Than Last Year

Dec 20

Is Now An Opportune Moment To Examine EC Healthcare (HKG:2138)?

Oct 25

EC Healthcare (HKG:2138) Is Reinvesting At Lower Rates Of Return

Sep 20

EC Healthcare's (HKG:2138) Dividend Will Be Reduced To HK$0.042

Sep 01

EC Healthcare's (HKG:2138) Shareholders Will Receive A Smaller Dividend Than Last Year

Jul 28

EC Healthcare's (HKG:2138) Dividend Will Be Reduced To HK$0.042

Jul 14

EC Healthcare (HKG:2138) Is Reducing Its Dividend To HK$0.042

Jun 26

When Should You Buy EC Healthcare (HKG:2138)?

May 26

EC Healthcare (HKG:2138) Will Be Hoping To Turn Its Returns On Capital Around

Apr 18

Is It Too Late To Consider Buying EC Healthcare (HKG:2138)?

Feb 24

EC Healthcare (HKG:2138) Could Easily Take On More Debt

Feb 11

CEO Tazminat Analizi

Leslie Lu'un ücretlendirmesi EC Healthcare'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Mar 31 2024	HK$5m	HK$5m	-HK$19m
Dec 31 2023	n/a	n/a	-HK$11m
Sep 30 2023	n/a	n/a	-HK$4m
Jun 30 2023	n/a	n/a	HK$33m
Mar 31 2023	HK$21m	HK$4m	HK$70m
Dec 31 2022	n/a	n/a	HK$93m
Sep 30 2022	n/a	n/a	HK$117m
Jun 30 2022	n/a	n/a	HK$157m
Mar 31 2022	HK$13m	HK$2m	HK$198m

Tazminat ve Piyasa: Leslie 'nin toplam tazminatı ($USD 619.12K ), Hong Kong pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 233.50K ).

Tazminat ve Kazançlar: Leslie 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Leslie Lu (44 yo)

less than a year

Görev süresi

HK$4,818,000

Tazminat

Mr. Lyn Wade Lu, also known as Leslie, served as Co-Chief Executive Officer & Executive Director at EC Healthcare since August 23, 2021 until November 1, 2023. He serves as Chief Executive Officer at EC He...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Chi Fai Tang	Founder & Executive Chairman	9yrs	HK$1.24m	60.93% HK$ 512.8m
Lyn Wade Lu	Chief Executive Officer & Executive Director	less than a year	HK$4.82m	Veri yok
Heung Wing Lee	CFO & Executive Director	5.3yrs	HK$3.77m	0.057% HK$ 483.2k
Tai Cheung Wong	Chief Operating Officer	2.3yrs	Veri yok	Veri yok
Kelly Tsang	Associate Director of Accounting	no data	Veri yok	Veri yok
Kin Keung Chan	Chief Public Affairs Officer & Chief Dental Officer	2.3yrs	Veri yok	Veri yok
Katy Ip	Sales Director	no data	Veri yok	Veri yok
Chun Pu Chu	Chief Business Officer	4.2yrs	Veri yok	Veri yok
Chun Yu Chan	Chief Talent Officer	2.3yrs	Veri yok	Veri yok
Julie Chow	Chief Proposition Officer of Healthcare	1.8yrs	Veri yok	Veri yok
Chun Pong Siu	Company Secretary	7.2yrs	Veri yok	Veri yok

2.3yrs

Ortalama Görev Süresi

45yo

Ortalama Yaş

Deneyimli Yönetim: 2138 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.3 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Chi Fai Tang	Founder & Executive Chairman	9yrs	HK$1.24m	60.93% HK$ 512.8m
Lyn Wade Lu	Chief Executive Officer & Executive Director	3.3yrs	HK$4.82m	Veri yok
Heung Wing Lee	CFO & Executive Director	4.8yrs	HK$3.77m	0.057% HK$ 483.2k
Ching Nam Ma	Independent Non-Executive Director	8.8yrs	HK$240.00k	0.025% HK$ 213.0k
Andrew Look	Independent Non-Executive Director	8.8yrs	HK$220.00k	Veri yok
Kun Shing Luk	Non Executive Director	9.2yrs	HK$126.00k	0.24% HK$ 2.0m
Tsun Au	Independent Non-Executive Director	2.2yrs	HK$120.00k	Veri yok

8.8yrs

Ortalama Görev Süresi

44yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 2138 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 8.8 yıldır).

EC Healthcare Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Less than half of directors are independent

EC Healthcare, Annual General Meeting, Aug 23, 2024

EC Healthcare Announces the Resignation of Mr. Wong Chi Cheung as Executive Director and Chief Digital Officer of the Company with Effect from 31 December 2023

EC Healthcare Announces Executive Changes

EC Healthcare, Annual General Meeting, Aug 23, 2023

Less than half of directors are independent

Recent updates

New minor risk - Market cap size

EC Healthcare (HKG:2138) Will Want To Turn Around Its Return Trends

EC Healthcare to Report First Half, 2025 Results on Nov 28, 2024

Ec Healthcare Provides Sales Expectations for Six Months Ended 30 September 2024

Price target increased by 35% to HK$2.84

Less than half of directors are independent

Little Excitement Around EC Healthcare's (HKG:2138) Revenues As Shares Take 31% Pounding

EC Healthcare Provides Group Earnings Guidance for the Period from 1 April 2024 to 30 June 2024

Full year 2024 earnings: EPS and revenues miss analyst expectations

EC Healthcare (HKG:2138) Might Be Having Difficulty Using Its Capital Effectively

Full year 2024 earnings: EPS and revenues miss analyst expectations

EC Healthcare, Annual General Meeting, Aug 23, 2024

EC Healthcare to Report Fiscal Year 2024 Results on Jun 27, 2024

An undisclosed buyer entered into an agreement to acquire additional 51% stake in Preeminent Medical Centre Limited from EC Healthcare (SEHK:2138) for HKD 80.2 million.

EC Healthcare (HKG:2138) Surges 25% Yet Its Low P/S Is No Reason For Excitement

When Should You Buy EC Healthcare (HKG:2138)?

Is EC Healthcare (HKG:2138) A Risky Investment?

New minor risk - Share price stability

EC Healthcare (SEHK:2138) entered into sale and purchase agreement to acquire 6.49% stake in Pangenia Inc from Sharp Point Consultant Limited for HKD 17.4 million.

Slammed 26% EC Healthcare (HKG:2138) Screens Well Here But There Might Be A Catch

EC Healthcare's (HKG:2138) Dividend Is Being Reduced To HK$0.005

EC Healthcare Announces the Resignation of Mr. Wong Chi Cheung as Executive Director and Chief Digital Officer of the Company with Effect from 31 December 2023

Price target decreased by 15% to HK$5.22

First half 2024 earnings released: EPS: HK$0.006 (vs HK$0.068 in 1H 2023)

Here's What's Concerning About EC Healthcare's (HKG:2138) Returns On Capital

EC Healthcare Declares an Interim Dividend for the Six Months Ended 30 September 2023, Payable on January 19, 2024

Ec Healthcare Provides Earnings Guidance for the Six Months Ended 30 September 2023

EC Healthcare to Report First Half, 2024 Results on Nov 30, 2023

EC Healthcare Announces Executive Changes

At HK$3.13, Is EC Healthcare (HKG:2138) Worth Looking At Closely?

Ec Healthcare Approves Dividend for the Year Ended 31 March 2023, Payment Date Is 18 September 2023

Upcoming dividend of HK$0.042 per share at 2.6% yield

EC Healthcare (HKG:2138) Is Paying Out A Dividend Of HK$0.042

Ec Healthcare Approves Final Dividend for the Year Ended 31 March 2023

Is EC Healthcare (HKG:2138) Using Too Much Debt?

New minor risk - Earnings quality

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

EC Healthcare (HKG:2138) Has Announced A Dividend Of HK$0.042

Consensus EPS estimates fall by 31%

EC Healthcare (HKG:2138) Will Pay A Dividend Of HK$0.042

Price target decreased by 11% to HK$8.03

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

EC Healthcare, Annual General Meeting, Aug 23, 2023

EC Healthcare Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 March 2023

Is There Now An Opportunity In EC Healthcare (HKG:2138)?

EC Healthcare to Report Fiscal Year 2023 Final Results on Jun 23, 2023

Be Wary Of EC Healthcare (HKG:2138) And Its Returns On Capital

Is EC Healthcare (HKG:2138) Potentially Undervalued?

EC Healthcare (HKG:2138) Will Want To Turn Around Its Return Trends

Price target increased to HK$9.33

Price target increased to HK$8.04

Upcoming dividend of HK$0.058 per share

EC Healthcare (HKG:2138) Is Paying Out Less In Dividends Than Last Year

Investor sentiment improved over the past week

Consensus forecasts updated

First half 2023 earnings released

EC Healthcare Announces Interim Dividend for the Six Months Ended 30 September 2022, Payable on 20 January 2023

Price target decreased to HK$8.89

Less than half of directors are independent

EC Healthcare Provides Earnings Guidance for the Six Months Ended 30 September 2022

EC Healthcare to Report Q2, 2023 Results on Nov 24, 2022

Investor sentiment improved over the past week

Is Now An Opportune Moment To Examine EC Healthcare (HKG:2138)?

Price target decreased to HK$10.17

Investor sentiment deteriorated over the past week

EC Healthcare (HKG:2138) Is Reinvesting At Lower Rates Of Return

Chairman & Co-CEO recently bought HK$587k worth of stock

EC Healthcare's (HKG:2138) Dividend Will Be Reduced To HK$0.042

EC Healthcare Announces Executive Changes